Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of febuxostat, once daily (QD) or twice
daily (BID), on renal function in gout patients with elevated serum urate levels and who have
moderate to severe renal impairment.